Smith+Nephew announces $330m acquisition of CartiHeal for innovative cartilage regeneration technology

Smith+Nephew announces $330m acquisition of CartiHeal for innovative cartilage regeneration technology

Smith+Nephew, a global medical technology leader, today announced its definitive agreement to acquire CartiHeal, the developer of Agili-C, a novel sports medicine technology. The acquisition, valued at up to $330 million, includes an initial cash consideration of $180 million and up to $150 million contingent on financial performance. Innovative Treatment with Agili-C Agili-C represents a […]